Bemotrizinol — already common in Mexico, Canada and South Korea — won FDA approval on June 9, ending a 27-year freeze on new OTC sunscreen ingredients.
Source: [Fortune](https://fortune.com/2026/06/21/bemotrizinol-fda-sunscreen-approval-europe-us-gap/)